Our investigation focus on the novel functions of two enzymes, originally named kininase I and II that cleave bonds of vasoactive peptides but now their importance extends beyond hydrolyzing peptides. Our first two specific aims are concerned with carboxypeptidase N (CPN), a tetramer of two active and two regulatory subunits. CPN cleaves the C-terminal basic amino acids of proteins and peptides. We will determine how each of the subunits is involved in converting creatine kinase to its subforms. We will use both purified and recombinant enzyme, the latter in quantities sufficient for X-ray crystallography. Our plan is to establish the genomic sequence of both subunits, although they are synthesized on different chromosomes. We will also explore the complex interrelationship of human CPN with the plasmin-plasminogen system, which may affect plasminogen activation and blood clotting. We will determine where the subunits of CPN are cleaved by plasmin, establish the consequences of this cleavage for stability and activity, and measure dissociation of the tetramer. Furthermore, we will see how a complex of the plasmin or plasminogen is formed with the active subunit. The third and fourth specific aims of our research are concerned with the mode of action of angiotensin converting enzyme (kininase II, ACE) inhibitors. These drugs are used by millions of patients, and some of their beneficial effects are attributed to potentiation of bradykinin. We will employ cells transfected with cDNA of human ACE and bradykinin B2 receptor and cultured cells constitutively expressing ACE and B2 receptors to investigate augmentation of the release of signal transduction products by B2 receptor ligands. Inhibitors and slowly hydrolyzed substrates can combine with the active center of membrane- bound ACE and thereby enhance the activity of ligands of the 7- transmembrane B2 receptor, even if the agonists are resistant to ACE. Thus, the actions of ACE inhibitor go beyond protecting bradykinin against inactivation, although they do not act directly on its receptor. We will also employ ultrastructural analysis and microscopy to establish morphologic correlates of functional activities. Our ultimate goal is to show how ACE inhibitors exert their beneficial effects on heart, kidney, etc., by enhancing peptide action at the receptor level.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL036473-15
Application #
6183016
Study Section
Cardiovascular and Renal Study Section (CVB)
Project Start
1988-05-01
Project End
2003-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
15
Fiscal Year
2000
Total Cost
$345,746
Indirect Cost
Name
University of Illinois at Chicago
Department
Pharmacology
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Huan, Tianxiao; Joehanes, Roby; Schurmann, Claudia et al. (2016) A whole-blood transcriptome meta-analysis identifies gene expression signatures of cigarette smoking. Hum Mol Genet 25:4611-4623
Lowry, Jessica L; Brovkovych, Viktor; Zhang, Yongkang et al. (2013) Endothelial nitric-oxide synthase activation generates an inducible nitric-oxide synthase-like output of nitric oxide in inflamed endothelium. J Biol Chem 288:4174-93
Zhang, Xianming; Lowry, Jessica L; Brovkovych, Viktor et al. (2012) Characterization of dual agonists for kinin B1 and B2 receptors and their biased activation of B2 receptors. Cell Signal 24:1619-31
Brovkovych, Viktor; Zhang, Yongkang; Brovkovych, Svitlana et al. (2011) A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase. J Cell Mol Med 15:258-69
Erdös, Ervin G; Tan, Fulong; Skidgel, Randal A (2010) Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension 55:214-20
Skidgel, Randal A; Erdos, Ervin G (2007) Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator. Int Immunopharmacol 7:1888-99
Keil, Cora; Maskos, Klaus; Than, Manuel et al. (2007) Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain. J Mol Biol 366:504-16
Chen, Zhenlong; Deddish, Peter A; Minshall, Richard D et al. (2006) Human ACE and bradykinin B2 receptors form a complex at the plasma membrane. FASEB J 20:2261-70
Stanisavljevic, Sinisa; Ignjatovic, Tatjana; Deddish, Peter A et al. (2006) Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells. J Pharmacol Exp Ther 316:1153-8
Hecquet, Claudie; Biyashev, Dauren; Tan, Fulong et al. (2006) Positive cooperativity between the thrombin and bradykinin B2 receptors enhances arachidonic acid release. Am J Physiol Heart Circ Physiol 290:H948-58

Showing the most recent 10 out of 77 publications